OBJECTIVE: To create a core set of measurement concepts for use in the creation and maintenance of anti-tumor necrosis factor-alpha patient registries in ankylosing spondylitis (AS). METHODS: A Delphi-based approach was used to identify elements that best identify a patient's clinical state, disease progression, and potential drug-related toxicities. Decision-making was based on systematic literature reviews and clinical experience and expertise. RESULTS: A core set of measurement domains was defined including disease activity and physical function outcomes. Comparison with domains used in existing AS registries showed excellent agreement with current practice. CONCLUSION: This core set is a basis for data collection across AS populations.
OBJECTIVE: To create a core set of measurement concepts for use in the creation and maintenance of anti-tumor necrosis factor-alphapatient registries in ankylosing spondylitis (AS). METHODS: A Delphi-based approach was used to identify elements that best identify a patient's clinical state, disease progression, and potential drug-related toxicities. Decision-making was based on systematic literature reviews and clinical experience and expertise. RESULTS: A core set of measurement domains was defined including disease activity and physical function outcomes. Comparison with domains used in existing AS registries showed excellent agreement with current practice. CONCLUSION: This core set is a basis for data collection across AS populations.
Authors: Shervin Assassi; Michael H Weisman; MinJae Lee; Laurie Savage; Laura Diekman; Tiffany A Graham; Mohammad H Rahbar; Joan I Schall; Lianne S Gensler; Atul A Deodhar; Daniel O Clegg; Robert A Colbert; John D Reveille Journal: Arthritis Rheumatol Date: 2014-09 Impact factor: 10.995
Authors: Olalekan Lee Aiyegbusi; Lavinia Ferrante di Ruffano; Ameeta Retzer; Philip N Newsome; Christopher D Buckley; Melanie J Calvert Journal: Trials Date: 2022-01-15 Impact factor: 2.279
Authors: Lianne D Peppel; Majanka H Heijenbrok-Kal; Thomas A Van Essen; Godard C W De Ruiter; Wilco C Peul; Gerard M Ribbers Journal: J Rehabil Med Date: 2022-01-11 Impact factor: 2.912